SI2176253T1 - Postopek priprave ali čiščenja olmesartan medoksomila ali hidrohalidne soli olmesartan medoksomila - Google Patents
Postopek priprave ali čiščenja olmesartan medoksomila ali hidrohalidne soli olmesartan medoksomilaInfo
- Publication number
- SI2176253T1 SI2176253T1 SI200830507T SI200830507T SI2176253T1 SI 2176253 T1 SI2176253 T1 SI 2176253T1 SI 200830507 T SI200830507 T SI 200830507T SI 200830507 T SI200830507 T SI 200830507T SI 2176253 T1 SI2176253 T1 SI 2176253T1
- Authority
- SI
- Slovenia
- Prior art keywords
- olmesartan medoxomil
- purification
- preparation
- hydrohalide salt
- olmesartan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07114000A EP2022790A1 (en) | 2007-08-08 | 2007-08-08 | A process for the preparation or purification of olmesartan medoxomil |
EP07114004A EP2036904A1 (en) | 2007-08-08 | 2007-08-08 | A process for the preparation of olmesartan medoxomil |
EP08786993A EP2176253B1 (en) | 2007-08-08 | 2008-08-07 | A process for the preparation or purification of olmesartan medoxomil or olmesartan medoxomil hydrohalide salt |
PCT/EP2008/060396 WO2009019303A2 (en) | 2007-08-08 | 2008-08-07 | A process for the preparation or purification of olmesartan medoxomil |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2176253T1 true SI2176253T1 (sl) | 2012-02-29 |
Family
ID=39789494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200830507T SI2176253T1 (sl) | 2007-08-08 | 2008-08-07 | Postopek priprave ali čiščenja olmesartan medoksomila ali hidrohalidne soli olmesartan medoksomila |
Country Status (9)
Country | Link |
---|---|
US (2) | US20110224271A1 (sl) |
EP (2) | EP2173741B1 (sl) |
JP (2) | JP5685082B2 (sl) |
CN (2) | CN101778842B (sl) |
AT (1) | ATE528305T1 (sl) |
BR (2) | BRPI0815134A2 (sl) |
CA (2) | CA2707365A1 (sl) |
SI (1) | SI2176253T1 (sl) |
WO (2) | WO2009019304A1 (sl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2173741B1 (en) * | 2007-08-08 | 2013-10-02 | LEK Pharmaceuticals d.d. | A process for the preparation of olmesartan medoxomil |
EP2298763B1 (en) | 2008-06-09 | 2015-03-25 | Daiichi Sankyo Company, Limited | Method for producing 1-biphenylmethylimidazole compound |
SG175296A1 (en) * | 2009-04-28 | 2011-11-28 | Daiichi Sankyo Co Ltd | Novel solvate crystals |
WO2010126013A1 (ja) | 2009-04-28 | 2010-11-04 | 第一三共株式会社 | オルメサルタンメドキソミルの製造方法 |
WO2011007368A2 (en) * | 2009-07-14 | 2011-01-20 | Cadila Healthcare Limited | An improved process for preparation of olmesartan |
WO2011013096A1 (en) * | 2009-07-31 | 2011-02-03 | Ranbaxy Laboratories Limited | Polymorphic form of olmesartan medoxomil |
WO2011021224A2 (en) * | 2009-08-19 | 2011-02-24 | Msn Laboratories Limited | Process for (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4-[2-tetrazol-5-yl)phenyl]phenyl]methylimidazole-5-carboxylate |
CZ2010785A3 (cs) * | 2010-10-29 | 2012-05-16 | Zentiva, K.S. | Zpusob výroby olmesartanu medoxomilu |
KR101275092B1 (ko) * | 2011-05-19 | 2013-06-17 | 한미정밀화학주식회사 | 아질사르탄의 개선된 제조방법 |
CN102351849B (zh) * | 2011-10-26 | 2013-10-02 | 齐鲁天和惠世制药有限公司 | 一种奥美沙坦酯的制备方法 |
CN103304550B (zh) * | 2012-03-16 | 2016-01-27 | 湖南欧亚生物有限公司 | 一种奥美沙坦酯的制备方法 |
CN103319461A (zh) * | 2013-07-02 | 2013-09-25 | 临海天宇药业有限公司 | 奥美沙坦酯中间体的制备方法以及奥美沙坦酯的合成方法 |
CN103435602A (zh) * | 2013-07-31 | 2013-12-11 | 山东省医学科学院药物研究所 | 一种奥美沙坦酯的制备方法 |
CN104262332A (zh) * | 2014-09-16 | 2015-01-07 | 上海信谊百路达药业有限公司 | 一种奥美沙坦酯的制备方法 |
CN104447715B (zh) * | 2014-11-28 | 2017-06-20 | 山东新华制药股份有限公司 | 奥美沙坦酯的制备方法 |
CN104817546B (zh) * | 2015-05-20 | 2020-02-07 | 浙江华海药业股份有限公司 | 一种奥美沙坦酯母液回收的方法 |
CN107311990B (zh) * | 2017-07-25 | 2021-09-03 | 浙江华海致诚药业有限公司 | 一种奥美沙坦酯的制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
ATE199548T1 (de) * | 1992-06-02 | 2001-03-15 | Sankyo Co | 4-carboxyimidazolderivate als angiotensin-ii- antagonisten und ihre therapeutische verwendung |
JP2001226372A (ja) * | 1999-12-06 | 2001-08-21 | Sumika Fine Chemicals Co Ltd | ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法 |
ITMI20032338A1 (it) * | 2003-11-28 | 2005-05-29 | Dinamite Dipharma S P A In Forma A Bbreviata Diph | Composti feniltetrazolici. |
CN1976926A (zh) | 2004-09-02 | 2007-06-06 | 特瓦制药工业有限公司 | 奥美沙坦酯的制备 |
CA2575177A1 (en) * | 2004-09-02 | 2006-03-16 | Teva Pharmaceutical Industries Ltd. | Purification of olmesartan medoxomil |
GB2419592A (en) * | 2004-10-26 | 2006-05-03 | Cipla Ltd | Process for the preparation of irbesartan hydrochloride |
US20060281800A1 (en) | 2005-04-12 | 2006-12-14 | Glenmark Pharmaceuticals Limited | Polymorphic form of olmesartan and process for its preparation |
EP1910343B1 (en) | 2005-07-29 | 2014-10-29 | Krka | Process for the preparation of olmesartan medoxomil |
EP1816131A1 (en) | 2006-02-06 | 2007-08-08 | KRKA, tovarna zdravil, d.d., Novo mesto | Process for the preparation of olmesartan medoxomil |
WO2007052301A2 (en) | 2005-08-31 | 2007-05-10 | Alembic Limited | Process for the preparation of irbesartan |
EP1801111B1 (en) * | 2005-12-20 | 2014-07-16 | LEK Pharmaceuticals d.d. | Novel polymorph forms of olmesartan medoxomil |
ES2371910T3 (es) | 2006-04-07 | 2012-01-11 | Lek Pharmaceuticals D.D. | Procedimiento para la preparación de irbesartán puro. |
WO2007148344A2 (en) | 2006-06-19 | 2007-12-27 | Matrix Laboratories Limited | Process for the preparation of olmesartan medoxomil |
EP2074116A2 (en) * | 2006-10-09 | 2009-07-01 | Cipla Limited | Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil |
EP2173741B1 (en) * | 2007-08-08 | 2013-10-02 | LEK Pharmaceuticals d.d. | A process for the preparation of olmesartan medoxomil |
-
2008
- 2008-08-07 EP EP08786996.2A patent/EP2173741B1/en not_active Not-in-force
- 2008-08-07 AT AT08786993T patent/ATE528305T1/de not_active IP Right Cessation
- 2008-08-07 CN CN200880102267.4A patent/CN101778842B/zh not_active Expired - Fee Related
- 2008-08-07 US US12/672,264 patent/US20110224271A1/en not_active Abandoned
- 2008-08-07 WO PCT/EP2008/060400 patent/WO2009019304A1/en active Application Filing
- 2008-08-07 EP EP08786993A patent/EP2176253B1/en not_active Not-in-force
- 2008-08-07 BR BRPI0815134-2A2A patent/BRPI0815134A2/pt not_active Application Discontinuation
- 2008-08-07 US US12/672,267 patent/US8592474B2/en active Active
- 2008-08-07 SI SI200830507T patent/SI2176253T1/sl unknown
- 2008-08-07 JP JP2010519468A patent/JP5685082B2/ja not_active Expired - Fee Related
- 2008-08-07 CA CA2707365A patent/CA2707365A1/en not_active Abandoned
- 2008-08-07 JP JP2010519469A patent/JP2010535743A/ja active Pending
- 2008-08-07 CN CN200880102268A patent/CN101778843A/zh active Pending
- 2008-08-07 CA CA2707334A patent/CA2707334C/en not_active Expired - Fee Related
- 2008-08-07 BR BRPI0815111-3A2A patent/BRPI0815111A2/pt not_active Application Discontinuation
- 2008-08-07 WO PCT/EP2008/060396 patent/WO2009019303A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA2707334C (en) | 2015-11-24 |
WO2009019303A2 (en) | 2009-02-12 |
JP2010535743A (ja) | 2010-11-25 |
BRPI0815111A2 (pt) | 2015-01-27 |
EP2176253B1 (en) | 2011-10-12 |
CA2707334A1 (en) | 2009-02-12 |
US8592474B2 (en) | 2013-11-26 |
EP2176253A2 (en) | 2010-04-21 |
WO2009019303A3 (en) | 2009-04-02 |
JP5685082B2 (ja) | 2015-03-18 |
CA2707365A1 (en) | 2009-02-12 |
EP2173741A1 (en) | 2010-04-14 |
EP2173741B1 (en) | 2013-10-02 |
JP2010535742A (ja) | 2010-11-25 |
US20110263666A1 (en) | 2011-10-27 |
BRPI0815134A2 (pt) | 2015-02-03 |
ATE528305T1 (de) | 2011-10-15 |
CN101778842A (zh) | 2010-07-14 |
CN101778843A (zh) | 2010-07-14 |
WO2009019304A1 (en) | 2009-02-12 |
CN101778842B (zh) | 2014-10-29 |
US20110224271A1 (en) | 2011-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI2176253T1 (sl) | Postopek priprave ali čiščenja olmesartan medoksomila ali hidrohalidne soli olmesartan medoksomila | |
MY149731A (en) | Compounds | |
IN2012DN02756A (sl) | ||
UY32062A (es) | Inhibidores de beta-secretasa | |
MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
MA32257B1 (fr) | Hydroxymethyl pyrrolidines comme agonistes des recepteurs beta-3- adrenergiques. | |
TN2011000414A1 (en) | Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitors, and uses thereof | |
EA201171151A1 (ru) | Кристаллические трипептидные ингибиторы эпоксикетон-протеазы | |
UA105033C2 (uk) | Фармацевтична композиція, що включає глюкопіранозилзаміщене похідне бензолу, фармацевтична дозована форма, що містить зазначене похідне, їх застосування для лікування метаболічного порушення | |
EA201190235A1 (ru) | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 | |
GT201200164A (es) | "nuevos compuestos de espiropiperidina" | |
IN2012DN03182A (sl) | ||
WO2010049449A3 (en) | Novel salts of sunitinib | |
IN2012DN02793A (sl) | ||
BRPI0911678B8 (pt) | maleato de orvepitant cristalino anidro, composição farmacêutica compreedendo o dito maleato e uso do mesmo para o tratamento ou profilaxia de doenças do sistema nervoso central | |
IN2012DN01292A (sl) | ||
WO2010098583A2 (ko) | 스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물 | |
UA94624C2 (uk) | Арипіпразолу геміфумарат і спосіб його одержання | |
TW200800993A (en) | Organic compounds | |
TN2010000266A1 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure | |
MX349563B (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
GB0615105D0 (en) | Novel compounds | |
MY152069A (en) | Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation threof, and therepeutic use thereof | |
MX2010006218A (es) | Compuestos organicos. | |
WO2011128699A3 (en) | Novel process for the preparation of sunitinib |